2.04 USD
↗ 0.06 (2.78%)LIVE (AS OF 02:53 PM EDT)
iBio, Inc. Common Stock
IBIONASDAQ • USD
Market: OPEN
Open?$1.99
High?$2.08
Low?$1.96
Prev. Close?$1.98
Volume?382.1K
Avg. Volume?1.1M
VWAP?$2.05
Rel. Volume?0.33x
Bid / Ask
Bid?$2.04 × 1.3K
Ask?$2.05 × 1.4K
Spread?$0.01
Midpoint?$2.05
Valuation & Ratios
Market Cap?68.4M
Shares Out?34.5M
Float?20.7M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?1.21
EPS?-$0.72
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?9.04Strong
Quick Ratio?9.04Strong
Cash Ratio?4.86Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.21CHEAP▾
P/S?227.99HIGH▾
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
EV/Sales?132.41HIGH▾
Returns & Efficiency
ROE?-43.7%WEAK▾
ROA?-38.4%WEAK▾
Cash Flow & Enterprise
FCF?$-19189000
Enterprise Value?$39.7M
Related Companies
Loading...
News
Profile
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
Address
600 MADISON AVENUE, SUITE 1601
NEW YORK, NY 10022-1737
Phone: 302 355-0650
NEW YORK, NY 10022-1737
Phone: 302 355-0650